Chapter 6 │ Page 213 References 1. Dos Santos, L.V., C.M. Abrahão, and W.N. William, Jr., Overcoming Resistance to Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinomas. Front Oncol, 2021. 11: p. 596290. 2. Passaro, A., et al., Managing Resistance to Immune Checkpoint Inhibitors in Lung Cancer: Treatment and Novel Strategies. Journal of Clinical Oncology, 2022. 40(6): p. 598-610. 3. Schoenfeld, A.J. and M.D. Hellmann, Acquired Resistance to Immune Checkpoint Inhibitors. Cancer Cell, 2020. 37(4): p. 443-455. 4. Abizanda-Campo, S., et al., Microphysiological systems for solid tumor immunotherapy: opportunities and challenges. Microsystems & Nanoengineering, 2023. 9(1): p. 154. 5. Tsumura, A., D. Levis, and J.M. Tuscano, Checkpoint inhibition in hematologic malignancies. Frontiers in Oncology, 2023. 13. 6. Chen, Q., L. Lu, and W. Ma, E icacy, Safety, and Challenges of CAR T-Cells in the Treatment of Solid Tumors. Cancers (Basel), 2022. 14(23). 7. Montironi, C., C. Muñoz-Pinedo, and E. Eldering, Hematopoietic versus Solid Cancers and T Cell Dysfunction: Looking for Similarities and Distinctions. Cancers (Basel), 2021. 13(2). 8. Bi, W.L., et al., Artificial intelligence in cancer imaging: Clinical challenges and applications. CA Cancer J Clin, 2019. 69(2): p. 127-157. 9. Pylvänäinen, J.W., et al., Live-cell imaging in the deep learning era. Current Opinion in Cell Biology, 2023. 85: p. 102271. 10. Deben, C., et al., OrBITS: label-free and time-lapse monitoring of patient derived organoids for advanced drug screening. Cell Oncol (Dordr), 2023. 46(2): p. 299-314. 11. Kasprzycka, W., et al., New approaches for low phototoxicity imaging of living cells and tissues. BioEssays, 2024. 46(5): p. 2300122. 12. Verswyvel, H., et al., Phototoxicity and cell passage a ect intracellular reactive oxygen species levels and sensitivity towards non-thermal plasma treatment in fluorescently-labeled cancer cells. Journal of Physics D: Applied Physics, 2023. 56(29): p. 294001. 13. Lin, A., et al., The e ect of local non-thermal plasma therapy on the cancerimmunity cycle in a melanoma mouse model. Bioengineering & Translational Medicine, 2022. 7(3): p. e10314. 14. Lin, A., et al., Non-Thermal Plasma as a Unique Delivery System of Short-Lived Reactive Oxygen and Nitrogen Species for Immunogenic Cell Death in Melanoma Cells. Advanced Science, 2019. 0(0): p. 1802062. 15. Lin, A., et al., Oxidation of Innate Immune Checkpoint CD47 on Cancer Cells with Non-Thermal Plasma. 2021. 13(3): p. 579. 16. Lin, A., et al., Nanosecond-Pulsed DBD Plasma-Generated Reactive Oxygen Species Trigger Immunogenic Cell Death in A549 Lung Carcinoma Cells through Intracellular Oxidative Stress. Int J Mol Sci, 2017. 18(5). 17. Bekeschus, S., et al., Medical Gas Plasma Jet Technology Targets Murine Melanoma in an Immunogenic Fashion. Advanced Science, 2020. 7(10): p. 1903438.
RkJQdWJsaXNoZXIy MTk4NDMw